Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

Tempus AI is developing innovative AI solutions for the treatment of cancer and other diseases. Shares of Tempus AI plummeted ...

Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report ...

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor ...

Spruce Point's short report sent Tempus AI stock down 20%. TEM shares were overvalued and risky to own even without the short ...

Tempus AI was targeted by a short seller last week ... Despite this, and the company's recent announcements, I believe that Tempus' stock is currently overvalued even if the short seller's ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at current levels. See why TEM is a Sell.

Tempus AI Inc. (TEM) stock tumbled nearly 18% in Wednesday’s regular trading session after Spruce Point published a report ...

Shares of Tempus AI (NASDAQ: TEM) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX ...

Based on its analysis, Spruce Point stated that Tempus AI stock has the potential to fall about 50% to 60%. From the stock's closing price on Tuesday (the day before Spruce Point released its ...